Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report

Abstract Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in ophthalmology 2022-09, Vol.13 (3), p.1024-1029
Main Authors: Rezkallah, Amina, Loria, Olivier, mathis, Thibaud, Chacun, Samuel, Denis, Philippe, Kodjikian, Laurent
Format: Article
Language:English
Subjects:
Case Report
Case reports
Edema
Eye surgery
fluocinolone acetonide implant
Glaucoma
Hypertension
Lasers
microinvasive bleb surgery
Ophthalmology
Patients
steroid-induced ocular hypertension
Steroids
Visual acuity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man with a history of bilateral DME who received an intravitreal injection of 190 µg fluocinolone acetonide (FAc) (ILUVIEN®, Alimera Sciences, Alpharetta, GA, USA) who presented a persistent ocular hypertension in one eye despite FAc removal by pars plana vitrectomy and was successfully managed by Preserflo® microshunt surgery.
ISSN:1663-2699
1663-2699
DOI:10.1159/000527672